title: Metastatic adrenocortical carcinoma with a prolonged response to mitotane.
authors.forename: Sumanta K
authors.initials: SK
authors.lastname: Pal
authors.forename: Benjamin
authors.initials: B
authors.lastname: Gartrell
authors.forename: Carl A
authors.initials: CA
authors.lastname: Olsson
authors.forename: C A
authors.initials: CA
authors.lastname: Stein
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000473:pathology* / Q000601:surgery; D000315:Adrenalectomy; D018268:Adrenocortical Carcinoma / Q000188:drug therapy* / Q000556:secondary*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008875:Middle Aged; D008939:Mitotane / Q000008:administration & dosage*; D049268:Positron-Emission Tomography; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane